New Enterprise Associates 14, L.P.

CIK 1544328 · last filed 2023-01-04

New Enterprise Associates 14, L.P. is a corporate insider who has filed 10 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for OYST, was dated Jan 4, 2023. Across all open-market trades the lifetime net is −$193.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $56.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$56.26M

Companies

6

Total Filings

10

Lifetime Open-Market Net

-$193.11M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Oyster Point Pharma, Inc. (OYST) Delisted 10%+ Owner 0 $11.17 $0 $0 1 2023-01-04
IMRA 10%+ Owner 3,305,601 $17.02 $56.26M -$2.89M 2 2022-01-25
Mersana Therapeutics, Inc. (MRSN) Delisted 10%+ Owner 5,959,520 $29.08 $173.30M $0 2 2020-09-16
Surface Oncology, Inc. (SURF) Delisted 10%+ Owner 3,179,544 $1.07 $3.40M $2.00M 1 2018-04-23
APPN 10%+ Owner 0 $24.01 $0 -$198.22M 3 2018-02-15
SYNLOGIC, INC. (MIRN) Delisted 10%+ Owner 1,499,166 $6.00M 1 2015-10-06

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-01-04 Oyster Point Pharma, Inc. (OYST) Delisted U −41,477,009 $0 EDGAR
2022-01-25 IMRA Sell (S) −1,076,464 -$1.62M EDGAR
2021-12-29 IMRA Sell (S) −539,416 -$1.28M EDGAR
2020-09-16 Mersana Therapeutics, Inc. (MRSN) Delisted Other (J) −2,000,000 $0 EDGAR
2020-04-13 Mersana Therapeutics, Inc. (MRSN) Delisted Other (J) −4,000,000 $0 EDGAR
2018-04-23 Surface Oncology, Inc. (SURF) Delisted Mixed +3,312,877 $2.00M EDGAR
2018-02-15 APPN Mixed $0 EDGAR
2017-11-27 APPN Mixed -$33.31M EDGAR
2017-11-21 APPN Mixed -$164.92M EDGAR
2015-10-06 SYNLOGIC, INC. (MIRN) Delisted Mixed +2,971,517 $6.00M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.